CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Apr. 03, 2015		Mar. 28, 2014
Cash flows from operating activities:
Net earnings	$ 199,283		$ 190,748
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	25,238		18,640
Tax benefits from exercises of share-based payment awards	11,144		8,544
Excess tax benefits from share-based compensation	(11,138)		(8,482)
Depreciation	30,111		28,701
Amortization of intangible assets	3,286		1,938
Deferred taxes	16,399		(14,567)
Provision for doubtful accounts receivable	6,682		5,633
(Income) loss from equity investment in affiliate	(525)		600
Other, net	2,039		(1,553)
Changes in assets and liabilities, net of effects of acquisition:
Accounts receivable	(17,457)		(99,465)
Inventories	(92,951)		(23,062)
Prepaid expenses and other assets	(20,987)		(5,354)
Accounts payable	(12,833)		(16,309)
Accrued expenses and other liabilities	(43,159)		45,074
Deferred revenues and advance payments from customers	37,134		38,027
Net cash provided by operating activities	132,266		169,113
Cash flows from investing activities:
Purchases of property, plant and equipment	(36,722)		(43,805)
Increase in restricted cash	(35,710)		0
Investment in available-for-sale corporate debt securities	(942)		(13,746)
Notes receivable	(5,000)		(500)
Net amounts received from deferred compensation plan trust account	3,102		0
Other	104		(856)
Net cash used in investing activities	(75,168)		(58,907)
Cash flows from financing activities:
Repurchases of common stock	(201,181)		(314,525)
Proceeds from issuance of common stock to employees	67,221		64,085
Excess tax benefits from share-based compensation	11,138		8,482
Employees' taxes withheld and paid for restricted stock and restricted stock units	(16,046)		(8,478)
Net borrowings under revolving credit facility agreements	100,000		0
Repayments under term loan facility	(25,000)		(37,500)
Capital contribution from noncontrolling interest holders	1,777		0
Other	(1,073)		(408)
Net cash used in financing activities	(63,164)		(288,344)
Effects of exchange rate changes on cash and cash equivalents	19,014		(726)
Net increase/(decrease) in cash and cash equivalents	12,948		(178,864)
Cash and cash equivalents at beginning of period	849,275	[1]	1,117,861
Cash and cash equivalents at end of period	$ 862,223		$ 938,997

[1] The condensed consolidated balance sheet as of September 26, 2014 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.